FDA deadlines threaten drug safety

被引：0

作者：

不详

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2008年 / 86卷 / 14期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Many drugs are approved against the deadline by FDA which might lead to unintended consequences with regard to drug safety. It is suggested that drug safety might improve under an FDA approval protocol that is more flexible and less driven by deadline pressures.

引用

页码：42 / 42

页数：1

共 50 条

[1] The Complications of Controlling Agency Time Discretion: FDA Review Deadlines and Postmarket Drug Safety
Carpenter, Daniel
Chattopadhyay, Jacqueline
Moffitt, Susan
Nall, Clayton
AMERICAN JOURNAL OF POLITICAL SCIENCE, 2012, 56 (01) : 98 - 114
[2] FDA sets geriatric drug use labeling deadlines
Skolnick, AA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (16): : 1302 - 1302
[3] DRUG SAFETY AND FDA
PISANI, JM
FOOD DRUG COSMETIC LAW JOURNAL, 1966, 21 (02): : 68 - 77
[4] Drug-review deadlines and safety problems
Carpenter, Daniel
Zucker, Evan James
Avorn, Jerry
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13): : 1354 - 1361
[5] Internal Deadlines, Drug Approvals, and Safety Problems
Cohen, Lauren
Gurun, Umit G.
Li, Danielle
AMERICAN ECONOMIC REVIEW-INSIGHTS, 2021, 3 (01) : 67 - 82
[6] Drug-review deadlines and safety problems
Nardinelli, Clark
Lanthier, Michael
Temple, Robert
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 95 - 96
[7] PLANNING LAW DEADLINES THREATEN STATE PROGRAMS
TENNENBAUM, D
HOSPITALS, 1979, 53 (08): : 75 - 77
[8] FDA and Postapproval Drug Safety
不详
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 25N - 25N
[9] Drug-review deadlines and safety problems - Reply
Carpenter, Daniel
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 96 - 98
[10] Drug-review deadlines linked to safety problems
Reactions Weekly, 2008, 1196 (1) : 1 - 1

← 1 2 3 4 5 →